Mibefradil a T‐type Ca2+ channel blocker also blocks Orai channels by action at the extracellular surface

摘要

Mibefradil, a T‐type Ca2+ channel blocker, has been investigated for treating solid tumours. However, its underlying mechanisms are still unclear. Here, we have investigated the pharmacological actions of mibefradil on Orai store‐operated Ca2+ channels.